News | PACS Accessories | June 13, 2019

M*Modal and Community Health Network Partner on AI-powered Clinical Documentation

With M*Modal, Community Health Network physicians save time with each patient encounter, and in after-hours clinical documentation tasks, creating time to care for patients and doctors alike

M*Modal and Community Health Network Partner on AI-powered Clinical Documentation

June 13, 2019 — M*Modal announced that the company and Community Health Network (CHNw) are collaborating to transform the patient-physician experience while improving provider and clinician satisfaction and care quality.

Community Physician Network, CHNw’s multidisciplinary provider group in Indiana, employs more than 1,100 physicians and advanced practice providers. Many more independent providers practice at Community. The strategic alliance with M*Modal is designed to make Epic electronic health record (EHR) documentation faster and easier for physicians and providers, and to maximize face time with patients.

After an extensive evaluation, Community Health Network selected M*Modal for its conversational artificial intelligence (AI) platform and physician-assistive services. With the M*Modal platform, Community Health Network is on the path to more ambient physician experiences that leverage smarter, AI-driven workflows including M*Modal Computer-Assisted Physician Documentation (CAPD) and Epic Haiku Voice Assistant.

“Over and above that, what really tipped the scales for us is that M*Modal is laser-focused on patient care and those who provide it,” said Michael Shrift, M.D., SVP and CMIO of Community Health Network. “M*Modal’s technological partnership is very human – for M*Modal, it is patient care and relationship primarily, with technology a support.”

The M*Modal platform enables Community Health Network clinicians to utilize any speech-driven workflow directly in the EHR including real-time speech recognition, mobile documentation, virtual scribing and transcription. With M*Modal Fluency Direct, physicians can capture complete and accurate notes in their Epic EHR. In the future, built-in CAPD will empower clinicians and virtual scribes with proactive and in-workflow clinical intelligence on care gaps, clinical documentation improvement (CDI), best practices and more.

“M*Modal Fluency Direct is very well accepted by our physicians and helps our overall program to tackle physician burnout. It is much more than speech-to-text technology. It gives us a fluid user interface in Epic and helpful speech commands. This has a positive impact on the EHR experience,” said Shrift.

To further drive physician satisfaction, Community Health Network is quickly rolling out the M*Modal virtual scribing solution to its physicians to transform the patient-physician interaction in the exam room. M*Modal virtual scribes allow doctors to focus on the patient and reduce the administrative burden on physicians, promoting improved safety, quality and patient experience.

According to Shrift, many Community Health Network physicians save considerable time after-hours and during the clinic day, doing less clinical documentation and administrative work. The healthcare organization is excited about the continued impact of the M*Modal platform on its high-priority physician well-being program.

Community Health Network is a non-profit health system with more than 200 sites of care and affiliates throughout central Indiana. Community’s full continuum of care integrates hundreds of physicians, specialty and acute care hospitals, surgery centers, home care services, MedChecks, behavioral health and employer health services.

For more information: www.mmodal.com

Related Content

Guerbet announced the launch of OptiProtect 3S, a new range of technical services for its injection solutions. OptiProtect 3S is designed to support imaging centers in the daily use and protection of their injection solutions.
News | Contrast Media Injectors | February 25, 2021
February 25, 2021 — Guerbet announced the launch of ...
icobrain cva allows the quantitative assessment of tissue perfusion by reporting the volume of core and perfusion lesion by quantifying Tmax abnormality and CBF abnormality together with the mismatch volume and ratio
News | Artificial Intelligence | February 23, 2021
February 23, 2021 — icometrix, world leader in imaging...
 Enterprise imaging systems provider Intelerad Medical Systems announced it has acquired Lumedx, a leading provider of healthcare analytics and cardiovascular information systems (CVIS). 
News | Enterprise Imaging | February 18, 2021
February 18, 2021 – Enterprise imaging systems provider Intelerad Medical Systems announced it has acquired...
GE Healthcare introduced its artificial intelligence (AI) automation features on its Voluson Swift ultrasound platform at the 2020 Radiological Society of North America (RSNA) virtual meeting. Features of this system include semi-automated contouring, auto identification of fetal anatomy and positioning on imaging. AI is seeing increasing integration in ultrasound systems from numerous vendors.

GE Healthcare introduced its artificial intelligence (AI) automation features on its Voluson Swift ultrasound platform at the 2020 Radiological Society of North America (RSNA) virtual meeting. Features of this system include semi-automated contouring, auto identification of fetal anatomy and positioning on imaging. AI is seeing increasing integration in ultrasound systems from numerous vendors.

Feature | Ultrasound Imaging | February 18, 2021 | By Dave Fornell, Editor
Recent advances in ultrasound image sy...
Example MR images from paediatric brain tumour patients. This first column shows T1-weighted images following the injection of gadolinium contrast agent. The second column shows T2-weighted images and the final column shows apparent diffusion coefficient maps calculated from diffusion-weighted images. (a–c) are taken from a patient with a Pilocytic Astrocytoma, (d–f) are from a patient with an Ependymoma and (g–i) were acquired from a patient with a Medulloblastoma.

Example MR images from paediatric brain tumour patients. This first column shows T1-weighted images following the injection of gadolinium contrast agent. The second column shows T2-weighted images and the final column shows apparent diffusion coefficient maps calculated from diffusion-weighted images. (ac) are taken from a patient with a Pilocytic Astrocytoma, (df) are from a patient with an Ependymoma and (gi) were acquired from a patient with a Medulloblastoma. Image courtesy of Nature Research Journal

News | Pediatric Imaging | February 17, 2021
February 17, 2021 — Diffusio...
Radiology, radiation therapy, PACS, Enterprise image, X-ray, DR Systems, CT, MRI, contrast, ultrasound, VNA, product comparisons, comparison charts on ITN magazine.
Feature | February 17, 2021
Imaging Technology News (ITN) maintains more than 40
The British Institute of Radiology supports the proposal by AXREM that staff members from private suppliers who work shoulder to shoulder with National Health Service (NHS) staff in high-risk areas in hospitals should be recognised as frontline health and social care staff and prioritised for COVID-19 vaccination accordingly.

Getty Images

News | Coronavirus (COVID-19) | February 12, 2021
February 12, 2021 — The British Institute of Radiology supports the proposal by...
The research collaboration agreement covers a joint clinical retrospective study on liver fibrosis severity in Non-Alcoholic Steato-Hepatitis (NASH) patients
News | Artificial Intelligence | February 10, 2021
February 10, 2021 — Median Technologies announced the company has signed a research collaboration agreement with the
Comparison of breast cancer mortality rates (red squares) and distant-stage breast cancer incidence rates from SEER9 (blue dots) and SEER18 (green dots) per 100,000 for white women aged, A, 20–39, B, 40–69, and, C, 70–79 years (3,7,8).

Comparison of breast cancer mortality rates (red squares) and distant-stage breast cancer incidence rates from SEER9 (blue dots) and SEER18 (green dots) per 100,000 for white women aged, A, 20–39, B, 40–69, and, C, 70–79 years (3,7,8). Image courtesy of Radiology 

News | Breast Imaging | February 10, 2021
February 10, 2021 — Breast cancer death rates have stopped declining for women in the U.S.